KEYS vs SER · P/E 57, rev $4.98B vs rev $56.0K
Keysight Technologies Inc (KEYS) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. SER currently screens at market cap $29.7M.
Not investment advice. Open the KEYS and SER stock pages for the full models.
Not investment advice.